Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy
Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy
Recruiting · NCT06941870 · Registry updated 2025-11-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, blood coagulation disease, coagulation protein disease, hematologic disorder, hemophilia A, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder | Recruiting | Phase 4 | 2025-11-18 | NCT06941870 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sanofi | 254 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Innovative Hematology, Inc.- Site Number : 8400006 | Indianapolis | United States | 1 |
| Ohio State University Hospital East- Site Number : 8400001 | Columbus | United States | 1 |
| Orthopedic Institute for Children- Site Number : 8400009 | Los Angeles | United States | 1 |
| University of Iowa- Site Number : 8400004 | Iowa City | United States | 1 |